Inventor · disambiguated record
Torsten Haack
Also filed as: HAACK TORSTEN
34 granted patents·5 pending applications·92 citations·filing 2008–2021
95Inventor score
Top patents by PatentIndex Score
39 records- 0191US9181305B2Exendin-4 peptide analoguesSANOFI SA·Filed 2013·Granted Nov 10, 2015·19 cites·44 claims
- 0290US9745360B2Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonistsSANOFI SA·Filed 2013·Granted Aug 29, 2017·14 cites·36 claims
- 0388US9750788B2Non-acylated exendin-4 peptide analoguesSANOFI SA·Filed 2014·Granted Sep 5, 2017·11 cites·23 claims
- 0487US9365632B2Exendin-4 derivatives as dual GLP1/glucagon agonistsSANOFI SA·Filed 2013·Granted Jun 14, 2016·9 cites·38 claims
- 0584US9758561B2Dual GLP-1/glucagon receptor agonists derived from exendin-4SANOFI SA·Filed 2015·Granted Sep 12, 2017·6 cites·34 claims
- 0684US8828994B2Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereofBOEHME THOMAS·Filed 2012·Granted Sep 9, 2014·4 cites·12 claims
- 0781US9775904B2Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonistsSANOFI SA·Filed 2015·Granted Oct 3, 2017·4 cites·27 claims
- 0881US9771406B2Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4SANOFI SA·Filed 2015·Granted Sep 26, 2017·4 cites·31 claims
- 0980US9789165B2Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonistsSANOFI SA·Filed 2014·Granted Oct 17, 2017·4 cites·23 claims
- 1080US9751926B2Dual GLP-1/GIP receptor agonistsSANOFI SA·Filed 2014·Granted Sep 5, 2017·4 cites·27 claims
- 1179US9694053B2Dual GLP-1/glucagon receptor agonistsSANOFI SA·Filed 2014·Granted Jul 4, 2017·4 cites·22 claims
- 1277US10538567B2Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonistsSANOFI SA·Filed 2017·Granted Jan 21, 2020·2 cites·38 claims
- 1377US10519211B2Compounds as peptidic GLP1/glucagon/GIP receptor agonistsSANOFI SA·Filed 2017·Granted Dec 31, 2019·2 cites·30 claims
- 1476US9982029B2Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonistsSANOFI SA·Filed 2016·Granted May 29, 2018·2 cites·34 claims
- 1576US9670261B2Functionalized exendin-4 derivativesSANOFI SA·Filed 2013·Granted Jun 6, 2017·2 cites·49 claims
- 1663US11046743B2Selective glucagon receptor agonists comprising a chelating moiety for imaging purposesANTAROS MEDICAL AB·Filed 2016·Granted Jun 29, 2021·1 cites·20 claims
- 1755US10758592B2Exendin-4 derivatives as dual GLP1/glucagon agonistsSANOFI SA·Filed 2017·Granted Sep 1, 2020·0 cites·23 claims
- 1854US10253079B2Functionalized Exendin-4 derivativesSANOFI SA·Filed 2017·Granted Apr 9, 2019·0 cites·30 claims
- 1952US2014088077A1Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicamentsSANOFI SA·Filed 2013·Application pending·0 cites
- 2050US8853208B2Amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicamentsSCHWINK LOTHAR·Filed 2008·Granted Oct 7, 2014·0 cites·23 claims
- 2150US8828991B2Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicamentsSCHWINK LOTHAR·Filed 2008·Granted Sep 9, 2014·0 cites·28 claims
- 2250US8822495B2Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicamentsSCHWINK LOTHAR·Filed 2008·Granted Sep 2, 2014·0 cites·31 claims
- 2350US8501771B2Aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicamentsSCHWINK LOTHAR·Filed 2008·Granted Aug 6, 2013·0 cites·36 claims
- 2450US2016220643A1Exendin-4 derivatives as dual glp1/glucagon agonistsSANOFI SA·Filed 2016·Application pending·0 cites
- 2550US2023127047A1Selective gip receptor agonists comprising a chelating moiety for imaging and therapy purposesANTAROS MEDICAL AB·Filed 2021·Application pending·0 cites
- 2647US8828995B2Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereofBOEHME THOMAS·Filed 2012·Granted Sep 9, 2014·0 cites·12 claims
- 2746US8895547B2Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereofBOEHME THOMAS·Filed 2012·Granted Nov 25, 2014·0 cites·12 claims
- 2846US2015166625A1Exendin-4 Peptide AnaloguesSANOFI SA·Filed 2014·Application pending·0 cites
- 2946US2017022260A9Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonistsSANOFI SA·Filed 2014·Application pending·0 cites
- 3044US8609731B2Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicamentsSCHWINK LOTHAR·Filed 2010·Granted Dec 17, 2013·0 cites·19 claims
- 3143US8901114B2Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereofBOEHME THOMAS·Filed 2012·Granted Dec 2, 2014·0 cites·11 claims
- 3242US8871758B2Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereofBOEHME THOMAS·Filed 2012·Granted Oct 28, 2014·0 cites·12 claims
- 3342US8710050B2Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereofBOEHME THOMAS·Filed 2012·Granted Apr 29, 2014·0 cites·12 claims
- 3441US10806797B2Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugateSANOFI SA·Filed 2016·Granted Oct 20, 2020·0 cites·28 claims
- 3541US8846666B2Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereofBOEHME THOMAS·Filed 2012·Granted Sep 30, 2014·0 cites·13 claims
- 3641US8809324B2Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereofBOEHME THOMAS·Filed 2012·Granted Aug 19, 2014·0 cites·13 claims
- 3739US11352405B2GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitisSANOFI SA·Filed 2018·Granted Jun 7, 2022·0 cites·17 claims
- 3839US8809325B2Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereofBOEHME THOMAS·Filed 2012·Granted Aug 19, 2014·0 cites·12 claims
- 3937US9932381B2Exendin-4 derivatives as selective glucagon receptor agonistsSANOFI SA·Filed 2015·Granted Apr 3, 2018·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Torsten Haack files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →